You are currently viewing a new version of our website. To view the old version click .

Pancreatic Fibrosis in Inflammation and Cancer

This special issue belongs to the section “Molecular Oncology“.

Special Issue Information

Dear Colleagues,

Pancreatic fibrosis is a condition that develops in diseases that affect the pancreas such as pancreatitis and cancer. It can evolve starting from changes in the physiology of cells that normally contribute to the homeostasis of the stroma in the tissue. Cells can be abnormally activated by signals from different origins and then can proliferate and contribute to the deposition of extracellular matrix components. The developed fibrotic tissue can impair the functions of pancreas, both exocrine and endocrine. The consequences may vary depending on the extent of the fibrosis but usually enhance the development of inflammatory or cancerous cells within the gland, being a result of major relevance to human health. Over the past few years, and especially at present, researchers are working on the identification of regulators of pancreatic fibrosis. Nowadays, it is accepted that pancreatic stellate cells (PSC) contribute significantly to these pathogenic processes. Moreover, interrelationship with other cell types of the pancreas, including developing cancer cells, is emerging as potential regulator of PSC pathophysiology. Therefore, the understanding of the cellular and molecular basis of cell-to-cell interconnection is of major relevance to the knowledge of pancreatic disease development and the potential discovery of a cure.

Dr. Antonio Gonzalez
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • pancreas
  • fibrosis
  • disease
  • inflammation
  • cancer

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Int. J. Mol. Sci. - ISSN 1422-0067